RSV has been the leading cause of infant hospitalizations before a vaccine and treatment became available 3 years ago.
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to ...
Coinfection with RSV and RV is common in hospitalized children, but the impact of order of infection on disease severity remains unclear, according to Emily Schultz, MPhil, a PhD candidate in ...
Noninvasive respiratory support has emerged as a cornerstone in the management of preterm infants with respiratory distress, offering an alternative to invasive mechanical ventilation and reducing ...
Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...
The study found that respiratory syncytial virus (RSV) infections conferred the highest risk of severe lower respiratory illness in infants, increasing the odds of serious illnesses nearly ninefold.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...
New York's paid family leave policy resulted in an 18% decrease in respiratory infection-related hospitalizations and emergency visits in infants 8 weeks or younger. A 27% reduction in RSV ...
Under current budget pressures in social and health care services, even small but effective improvements matter in everyday practice. A new study shows that valved holding chambers (VHCs) used to ...
Please provide your email address to receive an email when new articles are posted on . Receiving dexamethasone after 5 weeks of age raised the odds for death and/or severe bronchopulmonary dysplasia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results